Gene-Edited Cell Transplant Shows Promise in Early Human Trial

For people with type 1 diabetes, the body's immune system mistakenly destroys the insulin-producing cells in the pancreas. This forces people to rely on daily insulin injections or pumps to survive. Scientists have long hoped to replace these cells through transplantation, but the immune system kept attacking the transplanted cells, forcing patients to take powerful immune-suppressing medications for life.

Researchers have now developed a strategy to outsmart the immune system. Using CRISPR gene editing, they modified donor insulin-producing cells by deactivating two genes that normally flag cells as foreign invaders. They also enhanced a gene that sends signals telling immune cells to back off. The result: cells that can hide from immune attack.

In a first-of-its-kind human trial, researchers transplanted 80 million of these modified cells into a patient with type 1 diabetes. Twelve weeks later, the cells were still alive and functioning inside the patient's body—without triggering immune rejection and without requiring the patient to take immune-suppressing drugs.

The transplanted cells produced approximately 7% of the insulin the patient would need to stop insulin injections entirely. While this amount is modest, experts view it as a significant milestone. It demonstrates that the patient's own body can once again produce some of its own insulin, something that hasn't been possible since their diagnosis.

This early result opens a new research direction for type 1 diabetes and potentially other autoimmune diseases. However, much more work lies ahead. Researchers will need to conduct larger trials, determine how long transplanted cells survive, and figure out how to increase insulin production to clinically meaningful levels.

The approximately 2 million Americans living with type 1 diabetes represent a population that could potentially benefit from this approach—but only after rigorous testing and regulatory approval. This trial represents progress in understanding how to make cell transplantation work, not a treatment option available today.

Source: YouTube community video. Evidence type: Community video — lay discussion, not peer-reviewed research. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.